Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers

Roman M. Chabanon, Daphné Morel, Sophie Postel-Vinay

Open source

DOI
10.1016/j.semcancer.2019.09.018
Published
2020-04
Container
Seminars in Cancer Biology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.semcancer.2019.09.018,
  title = {Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers},
  author = {Roman M. Chabanon and Daphné Morel and Sophie Postel-Vinay},
  year = {2020},
  journal = {Seminars in Cancer Biology},
  doi = {10.1016/j.semcancer.2019.09.018},
  url = {https://doi.org/10.1016/j.semcancer.2019.09.018}
}

RIS

TY  - JOUR
TI  - Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers
AU  - Roman M. Chabanon
AU  - Daphné Morel
AU  - Sophie Postel-Vinay
PY  - 2020
JO  - Seminars in Cancer Biology
DO  - 10.1016/j.semcancer.2019.09.018
UR  - https://doi.org/10.1016/j.semcancer.2019.09.018
ER  - 

APA

Chabanon, R. M., Morel, D., & Postel-Vinay, S. (2020). Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2019.09.018

Source records